BUSINESS● LOWSep 8 · Sep 8, 2026, 9:38 AM
Switzerland's Sandoz aims to double sales by 2035 in expanded biosimilars push
Seeking Alpha Tech · western europe
Switzerland's Sandoz aims to double its sales by 2035, driven by an expanded push into biosimilars. This indicates the company's long-term growth strategy within the pharmaceutical market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS28m agoFAAN’s Vision for the Airport of the Future: Technology, infrastructure and passenger-centric innovationVanguard NigeriaBUSINESS31m agoSoutheast Asia’s EV boom sidelines local car parts suppliersSouth China Morning Post